Language: BG BG
← Back to results
Recruiting NCT06594913

Eating Disorders Genetics Initiative 2

Conditions: Anorexia Nervosa Bulimia Nervosa Binge-Eating Disorder Avoidant Restrictive Food Intake Disorder

Sponsor: University of North Carolina, Chapel Hill

trial.available_in: БГ
Overview
The overarching intention of the Eating Disorder Genetics Initiative 2 (EDGI2) is to increase sample size, diversity, and eating disorder phenotypes. The investigators are enrolling 20,000 new participants with anorexia nervosa (AN), bulimia nervosa (BN), binge-eating disorder (BED), avoidant/restrictive food intake disorder (ARFID), and controls in the US, Mexico, Australia, New Zealand, Sweden, and Denmark. A primary study goal is to enroll at least 30% of participants from underrepresented groups. Participants are asked to complete a series of questionnaires and submit a saliva sample for genotyping. The goal is to better understand eating disorders and how they relate to each other so that better treatments can be developed.
Who can participate
Inclusion Criteria: * A lifetime history of anorexia nervosa, bulimia nervosa, binge-eating disorder, avoidant restrictive food intake disorders or no history of any disordered eating behavior, based on DSM-5 criteria algorithms * Age 12-99 years, depending on country. (US enrollment age is 18-99) Exclusion Criteria: * History of subthreshold disordered eating behaviors.
Locations 5
Australia (1)
QIMR Berghofer
Brisbane , Queensland
Mexico (1)
Comenzar de Nuevo
Monterrey
New Zealand (1)
University of Otago
Christchurch , Canterbury
Sweden (1)
Karolinska Institutet
Stockholm
Lisa Dinkler, PhD
United States (1)
University of North Carolina at Chapel Hill
Chapel Hill , North Carolina
Technical details
Status
Recruiting
Study type
OBSERVATIONAL
Sex
Male and female
Minimum age
12 Years
Maximum age
99 Years
Healthy volunteers
No
Start date
28.10.2024
Completion date
01.08.2027
Registry ID
NCT06594913
Source
anzctr
trial.inquiry_btn

Information is automatically extracted from ClinicalTrials.gov. Consult your doctor before taking action.